BiotechTube
Home/Pipeline/ALT-803

ALT-803

Non-Muscle Invasive Bladder Cancer

Phase 2Active

Key Facts

Indication
Non-Muscle Invasive Bladder Cancer
Phase
Phase 2
Status
Active
Company
Beike Bio-Technology

About Beike Bio-Technology

China's leading adult stem cell therapy company developing novel cell therapies and immunotherapies for oncology and regenerative medicine applications.

View full company profile

Therapeutic Areas

OncologyImmunology

Other Non-Muscle Invasive Bladder Cancer Drugs

DrugCompanyPhase
LP-50 (Intravesical)Lipella PharmaceuticalsPreclinical
Non-Muscle Invasive Bladder Cancer Therapy (likely nadofaragene firadenovec/Adstiladrin)Finvector Vision TherapiesApproved
SP-563Stamford PharmaceuticalsPreclinical